Herrera discussed tubulointerstitial nephropathy associated with monoclonal immunoglobulins. Tubulointerstitial nephropathy is a renal disease that affects the tubules of the kidneys and the tissues that surround them, leading to the deterioration of kidney function. The mechanism provided a platform for devising a new therapeutic avenue to treat these conditions.
The Glomerular Disease Study and Trial Consortium (GlomCon) provides medical education based on the best available evidence and creates a platform for research collaboration among clinicians, academics and industry partners guided by patients’ and their caregivers’ needs.